Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rivo Health vs Strut Health

By GLP-1 ScorecardUpdated

Rivo Health
Site position #100

Lower grade

Strut Health
Site position #28

Higher grade

Score comparison

Strut Health has the higher recorded score — 79.4/100 to 71.7/100.

Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueStrut Health +16
74
90
Dose & formulationStrut Health +20
75
95
Clinical oversightRivo Health +22
77
55
Labs & monitoringRivo Health +3
63
60
FulfillmentStrut Health +4
84
88
Contract termsStrut Health +51
41
92
Rivo Health · top barStrut Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricRivo HealthStrut Health
WeighScore71.7/10079.4/100
GradeCC+
Site position#100#28
Semaglutide$149/mo advertised starting rate on annual plan (compounded; confirm selected charge and renewal)Oral from $99/30 days; injection from $129/mo; oral page conflicts at $199—confirm dose and renewal
Tirzepatide$199/mo advertised starting rate on annual plan (compounded; confirm selected charge and renewal)Oral $199/30 days; injection $219/mo—confirm prescribed dose, quantity and renewal
CoverageState eligibility unverified; confirm prescribing and dispensing availability for your addressFAQ says all states except Arkansas as of September 2024; confirm current medication and route eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Rivo Health

Site position #100 · C

Strengths

  • Advertises semaglutide and tirzepatide injection and oral options
  • Starting-price cards disclose an annual-plan condition
  • Advertises provider visits, nutrition support and dietitian access
  • Current public pages name Rivo Health, Inc. and a Rimo Health clinical network

What to consider

  • The $149/$199 labels are annual-plan starting rates; first charge, total obligation and renewal remain unverified
  • The selected cancellation and refund agreement has not been verified
  • Exact treating practice, dispensing branch and individual state/license eligibility remain unverified
  • Bundled service frequency, lab costs, supplied quantity and extra charges need selected-plan confirmation
Strut Health

Site position #28 · C+

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Strengths

  • Dedicated pages list separate oral and injectable semaglutide and tirzepatide prices
  • Provider consultations, follow-ups and shipping are advertised as included
  • Current help describes an account cancellation button; terms also provide an email route
  • Tirzepatide pages advertise flat pricing across strengths, subject to confirmation for the selected prescription

What to consider

  • Dedicated oral semaglutide page lists $99 while the general semaglutide page lists oral $199; help warns dose increases raise price
  • Product pages describe buccal semaglutide while dose help describes sublingual use; exact formula and instructions need confirmation
  • 48-hour cancellation descriptions differ between shipment and processing; processed prescriptions are not refundable
  • Assigned GLP-1 pharmacy and a required or included lab program were not established; the general state footprint is dated September 2024

Featured provider

Strut Health

Strut Health scores 79.4/100 (C+). Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard